Zanubrutinib, a targeted therapy used to treat lymphoma, typically costs $$1,500 to$$2,000 per month. The exact cost varies depending on the dosage, regional medical insurance policies, and purchase channels.
This medication must be used strictly under medical supervision. Patients should obtain it through formal medical institutions and follow the prescribed treatment regimen.
Factors Affecting Cost
Dosage and Treatment Course
The standard dosage of zanubrutinib is oral administration twice daily (160 mg per dose), requiring approximately 2 boxes per month (28 capsules per box). Costs may change accordingly if the dosage is adjusted.
Medical Insurance Reimbursement
Zanubrutinib is covered by medical insurance in some provinces, with patients usually paying 30%–50% out of pocket. Specific policies should be confirmed with local medical insurance authorities.
Purchase Channels
Prices may differ across hospitals, designated pharmacies, or charitable drug donation programs. Some pharmaceutical companies offer patient assistance programs to further reduce expenses.
Tips for Reducing Treatment Costs
Medical Insurance Consultation
Inquire with your attending physician or local medical insurance bureau about reimbursement conditions and procedures. Certain indications (e.g., mantle cell lymphoma) may be prioritized for insurance coverage.
Patient Assistance Programs
Follow patient support initiatives launched by pharmaceutical companies or foundations. Eligible patients may apply for cost reductions or installment payment plans.
Treatment Plan Optimization
Under medical guidance, assess the need for long-term use. Some patients may gradually reduce the dosage as their condition improves.
Important Precautions
Prescription Compliance
Zanubrutinib is a prescription-only medication. Do not adjust the dosage or discontinue use without medical advice. Regular follow-ups are required to monitor complete blood count, liver and kidney function, and other indicators.
Side Effect Management
Common adverse reactions include thrombocytopenia, infections, etc. Seek immediate medical attention if severe discomfort occurs.
Patients are advised to choose a treatment plan based on their individual condition, financial situation, and physician’s recommendations, and obtain the medication through formal channels to ensure therapeutic efficacy and safety.
